Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 206699
Company: AMNEAL PHARMS CO
Company: AMNEAL PHARMS CO
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| PARICALCITOL | PARICALCITOL | 0.002MG/ML (0.002MG/ML) | SOLUTION;INTRAVENOUS | Prescription | AP | No | No |
| PARICALCITOL | PARICALCITOL | 0.005MG/ML (0.005MG/ML) | SOLUTION;INTRAVENOUS | Prescription | AP | No | No |
| PARICALCITOL | PARICALCITOL | 0.01MG/2ML (0.005MG/ML) | SOLUTION;INTRAVENOUS | Prescription | AP | No | No |
Original Approvals or Tentative Approvals
| Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
|---|---|---|---|---|---|---|---|
| 03/09/2017 | ORIG-1 | Approval | STANDARD |
Label is not available on this site. |
Supplements
| Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
|---|---|---|---|---|---|
| 05/21/2019 | SUPPL-1 | Labeling-Package Insert |
Label is not available on this site. |
PARICALCITOL
SOLUTION;INTRAVENOUS; 0.002MG/ML (0.002MG/ML)
TE Code = AP
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
|---|---|---|---|---|---|---|---|---|
| PARICALCITOL | PARICALCITOL | 0.002MG/ML (0.002MG/ML) | SOLUTION;INTRAVENOUS | Prescription | No | AP | 207174 | ACCORD HLTHCARE |
| PARICALCITOL | PARICALCITOL | 0.002MG/ML (0.002MG/ML) | SOLUTION;INTRAVENOUS | Prescription | No | AP | 206699 | AMNEAL PHARMS CO |
| PARICALCITOL | PARICALCITOL | 0.002MG/ML (0.002MG/ML) | SOLUTION;INTRAVENOUS | Prescription | No | AP | 204910 | CAPLIN |
| PARICALCITOL | PARICALCITOL | 0.002MG/ML (0.002MG/ML) | SOLUTION;INTRAVENOUS | Prescription | No | AP | 091108 | SANDOZ |
| ZEMPLAR | PARICALCITOL | 0.002MG/ML (0.002MG/ML) | SOLUTION;INTRAVENOUS | Prescription | Yes | AP | 020819 | ABBVIE |
SOLUTION;INTRAVENOUS; 0.005MG/ML (0.005MG/ML)
TE Code = AP
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
|---|---|---|---|---|---|---|---|---|
| PARICALCITOL | PARICALCITOL | 0.005MG/ML (0.005MG/ML) | SOLUTION;INTRAVENOUS | Prescription | No | AP | 207174 | ACCORD HLTHCARE |
| PARICALCITOL | PARICALCITOL | 0.005MG/ML (0.005MG/ML) | SOLUTION;INTRAVENOUS | Prescription | No | AP | 206699 | AMNEAL PHARMS CO |
| PARICALCITOL | PARICALCITOL | 0.005MG/ML (0.005MG/ML) | SOLUTION;INTRAVENOUS | Prescription | No | AP | 204910 | CAPLIN |
| PARICALCITOL | PARICALCITOL | 0.005MG/ML (0.005MG/ML) | SOLUTION;INTRAVENOUS | Prescription | No | AP | 203897 | RISING |
| PARICALCITOL | PARICALCITOL | 0.005MG/ML (0.005MG/ML) | SOLUTION;INTRAVENOUS | Prescription | No | AP | 091108 | SANDOZ |
| ZEMPLAR | PARICALCITOL | 0.005MG/ML (0.005MG/ML) | SOLUTION;INTRAVENOUS | Prescription | Yes | AP | 020819 | ABBVIE |
SOLUTION;INTRAVENOUS; 0.01MG/2ML (0.005MG/ML)
TE Code = AP
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
|---|---|---|---|---|---|---|---|---|
| PARICALCITOL | PARICALCITOL | 0.01MG/2ML (0.005MG/ML) | SOLUTION;INTRAVENOUS | Prescription | No | AP | 207174 | ACCORD HLTHCARE |
| PARICALCITOL | PARICALCITOL | 0.01MG/2ML (0.005MG/ML) | SOLUTION;INTRAVENOUS | Prescription | No | AP | 206699 | AMNEAL PHARMS CO |
| PARICALCITOL | PARICALCITOL | 0.01MG/2ML (0.005MG/ML) | SOLUTION;INTRAVENOUS | Prescription | No | AP | 204910 | CAPLIN |
| PARICALCITOL | PARICALCITOL | 0.01MG/2ML (0.005MG/ML) | SOLUTION;INTRAVENOUS | Prescription | No | AP | 203897 | RISING |
| PARICALCITOL | PARICALCITOL | 0.01MG/2ML (0.005MG/ML) | SOLUTION;INTRAVENOUS | Prescription | No | AP | 091108 | SANDOZ |
| ZEMPLAR | PARICALCITOL | 0.01MG/2ML (0.005MG/ML) | SOLUTION;INTRAVENOUS | Prescription | Yes | AP | 020819 | ABBVIE |